绝望地想睡觉:探索父母对神经发育障碍青少年中黑色素使用的看法
Alyson E Hanish1, Shelby M Freudenburg1, Abbey J Klein1
1College of Nursing, University of Nebraska Medical Center, Omaha, Nebraska, USA.
Journal for specialists in pediatric nursing : JSPN
|November 1, 2025
概括
父母报告说,黑激素改善了患有神经发育障碍 (NDD) 的青少年的睡眠,如自闭症谱系障碍 (ASD) 和多动症. 他们发现它是安全有效的,尽管品牌和剂量变化很常见.
科学领域:
- 神经发育障碍 神经发育障碍
- 青少年睡眠医学 青少年睡眠医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 睡眠障碍在患有神经发育障碍 (NDD) 的青少年中很普遍,包括自闭症谱系障碍 (ASD) 和注意力缺陷多动症障碍 (ADHD).
- 睡眠障碍可能会加剧NDD的核心症状,并对儿童和家庭的功能产生负面影响.
- 外源性黑激素是改善这一群体睡眠的潜在治疗选择.
研究的目的:
- 探讨家长与睡眠障碍,睡眠相关障碍的经验,以及在被诊断为NDD的青少年中使用外源性黑激素.
- 了解家长对黑激素有效性,安全性和孩子使用模式的看法.
主要方法:
- 定性研究涉及与26名青少年 (11-18岁) 患有自闭症和/或多动症的家长进行半结构面试.
- 传统的内容分析被用来分析采访数据.
主要成果:
- 所有的家长都报告说,他们的孩子已经存在睡眠开始困难.
- 父母描述了与睡眠相关的严重障碍,影响了孩子的行为,认知和家庭福祉.
- 父母认为黑激素是一种安全,自然和有效的干预措施,报告主观改善睡眠延迟,尽管常见的品牌和剂量调整.
结论:
- 黑色素似乎是一个主观安全和有效的干预睡眠障碍的青少年与NDDs.
- 在非处方药的黑激素产品中的不一致性需要对患者进行仔细的教育,以了解品牌和剂量变化.
- 需要进一步的研究来标准化青少年睡眠干预措施,并验证外源性黑激素的长期安全性和有效性.
更多相关视频
相关概念视频
Management of Insomnia
495
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
495
Substance Use Disorders Affecting Sleep
357
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
357
Sedatives and Hypnotics Drugs: Miscellaneous Agents
470
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
470
Nightmares and Night Terrors
404
Nightmares and night terrors represent two distinct types of sleep disturbances that differ in timing, characteristics, and the sleeper's recall of the event. Nightmares are vivid, disturbing dreams that usually awaken the sleeper from REM sleep, a stage of sleep where brain activity is high, and dreams are most frequent. Upon awakening, individuals often have detailed recollections of their nightmares, which can include themes of threats to survival, security, or self-esteem.
Nightmares...
Nightmares...
404
Pharmacokinetics in Pediatric Patients: Drug Metabolism
165
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
165
Attention-Deficit/Hyperactivity Disorder
709
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
709


